These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 20406165)
1. Expression and refolding technologies for production of recombinant proteins. Arakawa T Curr Pharm Biotechnol; 2010 Apr; 11(3):231-2. PubMed ID: 20406165 [No Abstract] [Full Text] [Related]
2. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications. Byrne H; Conroy PJ; Whisstock JC; O'Kennedy RJ Trends Biotechnol; 2013 Nov; 31(11):621-32. PubMed ID: 24094861 [TBL] [Abstract][Full Text] [Related]
3. A highly controllable reconstituted cell-free system--a breakthrough in protein synthesis research. Ohashi H; Kanamori T; Shimizu Y; Ueda T Curr Pharm Biotechnol; 2010 Apr; 11(3):267-71. PubMed ID: 20210745 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical and industrial protein engineering: where we are? Amara AA Pak J Pharm Sci; 2013 Jan; 26(1):217-32. PubMed ID: 23261751 [TBL] [Abstract][Full Text] [Related]
6. Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. Huang CJ; Lin H; Yang X J Ind Microbiol Biotechnol; 2012 Mar; 39(3):383-99. PubMed ID: 22252444 [TBL] [Abstract][Full Text] [Related]
7. Agrobacterium-mediated transient expression as an approach to production of recombinant proteins in plants. Sheludko YV Recent Pat Biotechnol; 2008; 2(3):198-208. PubMed ID: 19075868 [TBL] [Abstract][Full Text] [Related]
8. [The achievements and outlook in genetic engineering in the field of creating medical preparations]. Vorob'ev AA Vestn Ross Akad Med Nauk; 1993; (2):3-7. PubMed ID: 7688616 [No Abstract] [Full Text] [Related]
9. Recombinant protein production: a comparative view on host physiology. Sevastsyanovich Y; Alfasi S; Cole J N Biotechnol; 2009 Apr; 25(4):175-80. PubMed ID: 19429532 [TBL] [Abstract][Full Text] [Related]
10. Cell engineering and cultivation of chinese hamster ovary (CHO) cells. Omasa T; Onitsuka M; Kim WD Curr Pharm Biotechnol; 2010 Apr; 11(3):233-40. PubMed ID: 20210750 [TBL] [Abstract][Full Text] [Related]
11. Current status of technical protein refolding. Jungbauer A; Kaar W J Biotechnol; 2007 Feb; 128(3):587-96. PubMed ID: 17222934 [TBL] [Abstract][Full Text] [Related]
13. Upstream and Downstream of Recombinants Biomolecules to Health Care Industry. Mazzola PG; Cavaco-Paulo A; FarÃas JG; Pereira JF Biomed Res Int; 2016; 2016():9374847. PubMed ID: 27595111 [No Abstract] [Full Text] [Related]
14. Into the 21st century. Biotechnology and the pharmaceutical industry in the next ten years. Drews J Biotechnology (N Y); 1993 Mar; 11(3):S16-20. PubMed ID: 7763432 [No Abstract] [Full Text] [Related]
16. The high pH and pH-shift refolding technology. Lin X; Umetsu T Curr Pharm Biotechnol; 2010 Apr; 11(3):293-9. PubMed ID: 20210740 [TBL] [Abstract][Full Text] [Related]
18. Engineering challenges in the applications of rDNA technology: yesterday, today, and tomorrow. Humphrey A Ann N Y Acad Sci; 1994 May; 721():1-11. PubMed ID: 8010658 [No Abstract] [Full Text] [Related]
19. Use of oil bodies and oleosins in recombinant protein production and other biotechnological applications. Bhatla SC; Kaushik V; Yadav MK Biotechnol Adv; 2010; 28(3):293-300. PubMed ID: 20067829 [TBL] [Abstract][Full Text] [Related]
20. Cell-free protein synthesis: applications in proteomics and biotechnology. He M N Biotechnol; 2008; 25(2-3):126-32. PubMed ID: 18786663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]